Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring

Purpose

The goal of this study is to create a data set to add to Carevive's registry from real world clinical and patient reported data collected using an electronic care planning system (CPS) with remote symptom monitoring that is used in routine care for cancer patients on active treatment. Patients will complete a baseline survey in person using a secured device or remotely using their own electronic device in a location of their choice. Weekly electronic patient reported outcome (PRO) surveys are collected from the patients using the Carevive platform for a minimum of 12 weeks. Patients may continue weekly surveys as long as they are receiving treatment.

Conditions

  • Breast Cancer
  • Lung Cancer
  • Multiple Myeloma
  • Ovarian Cancer
  • Acute Myelogenous Leukemia

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • All participants must be 18 years of age or older. - Subjects may be any stage and anywhere in the treatment continuum. - Subject participants must have a diagnosis of a breast, lung, AML, ovarian cancer or multiple myeloma. - Subjects must be able to complete on-line surveys using a cell phone, tablet, or computer. - All participants must be able to understand English.

Exclusion Criteria

  • Any patient who cannot understand written or spoken English. - Any patient without the ability to complete on-line surveys using a cell phone, tablet, or computer. - Any patient on a treatment clinical trial. - Any prisoner and/or other vulnerable persons as defined by NIH (45 CFR 46, Subpart B, C and D).

Study Design

Phase
Study Type
Observational
Observational Model
Other
Time Perspective
Prospective

Recruiting Locations

Northshore University Health System
Evanston, Illinois 31024
Contact:
Michele Britto
MBritto@northshore.org

Cleveland Clinic Mercy Hospital
Canton, Ohio 44708
Contact:
Janet Muckley
MUCKLEJ@ccf.org

University Hospitals Seidman Cancer Center
Cleveland, Ohio 44106
Contact:
Jill Severino-Powell, MSN
Jill.Severino-Powell@UHhospitals.org

Tri-County Hematology & Oncology Associates, Inc.
Massillon, Ohio 44646
Contact:
Janet Muckley
MUCKLEJ@ccf.org

More Details

NCT ID
NCT05974150
Status
Recruiting
Sponsor
Carevive Systems, Inc.

Study Contact

JULIE SCOTT, MSN
8778423210
Julie.Scott@Carevive.com

For help using this page: trialstoday@researchmatch.org or call 855-514-7001

ResearchMatch is funded in part by the National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program, led by the NIH’s National Center for Advancing Translational Sciences (NCATS), grants UL1TR000445 and 1U54RR032646-01, and grant U24TR001579 from NCATS and the National Library of Medicine. The content of this website is solely the responsibility of ResearchMatch and Vanderbilt University and does not necessarily represent the official views of the NIH, NCATS, or NLM.

Vanderbilt University Medical Center